Sheila Rojas
Psychiatric/Mental Health · Miami, FLNPI 1619586591
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,125 and has fallen 97.9% since, to $45 in 2024. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$961
- Bayer$388
- Lilly USA, LLC$367
- Pfizer$342
- AstraZeneca$327
- Biohaven Pharmaceutical Holding Company Ltd.$307
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,78998%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $961 |
| Bayer | 20 | $388 |
| Lilly USA, LLC | 25 | $367 |
| Pfizer | 18 | $342 |
| AstraZeneca | 20 | $327 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $307 |
| Johnson & Johnson | 15 | $247 |
| GSK | 12 | $234 |
| Kowa Pharmaceuticals America, Inc. | 14 | $234 |
| Amgen | 13 | $211 |
| Boehringer Ingelheim | 11 | $180 |
| Shield Therapeutics Inc | 6 | $161 |
| Novo Nordisk | 8 | $145 |
| Novartis | 8 | $145 |
| Merck | 8 | $128 |
| Astellas Pharma US Inc | 2 | $107 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Biohaven Pharmaceuticals, Inc. | 4 | $85 |
| Amarin Pharma, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 3 | $57 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $16 |
How this compares
$4,874 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Miami
- Carlos LarrauriMiami$23K
- Sandra Pelaez-MurseyMiami$20K
- Rolando Gonzalez AriasMiami$18K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.